- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PARP inhibitor BMN-673
Total 1878 results
-
University of ChicagoNational Cancer Institute (NCI)CompletedColorectal CancerUnited States
-
Beijing Anzhen HospitalCompletedRandomized Controlled TrialsChina
-
TakedaWithdrawn
-
Peking Union Medical College HospitalRecruitingHepatocellular Carcinoma | PD-1 Inhibitor | RegorafenibChina
-
Bristol-Myers SquibbTerminatedUrinary Bladder NeoplasmsUnited States, Argentina, Australia, Brazil, Canada, Chile, China, France, Mexico, Netherlands, Spain, United Kingdom, Italy, Hong Kong, Russian Federation
-
Bristol-Myers SquibbCompletedAdvanced Solid TumorsChina
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruiting
-
Intergroupe Francophone du MyelomeJanssen Research & Development, LLC; HOVON - Dutch Haemato-Oncology AssociationActive, not recruitingMultiple MyelomaNetherlands, France, Belgium
-
University of DundeeCompleted
-
GlaxoSmithKlineWithdrawnAlzheimer's DiseaseUnited States, United Kingdom
-
National Institute of Allergy and Infectious Diseases...Hoffmann-La Roche; Glaxo WellcomeCompleted
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruiting
-
Verastem, Inc.TerminatedPancreatic CancerUnited States
-
Asociación para Evitar la Ceguera en MéxicoUnknown* Diffuse Diabetic Macular EdemaMexico
-
Hull University Teaching Hospitals NHS TrustMerck Sharp & Dohme LLCCompletedPolycystic Ovary SyndromeUnited Kingdom
-
M.D. Anderson Cancer CenterRecruitingRenal Medullary Carcinoma | CarcinomasUnited States
-
Bristol-Myers SquibbRecruitingClear Cell Renal Cell CarcinomaRussian Federation, New Zealand, United States, Finland, France, Ireland, Italy, Turkey, Poland, Argentina, Brazil, Chile, Czechia, Mexico, Portugal, Romania, Spain
-
The Netherlands Cancer InstituteBristol-Myers SquibbCompletedUrothelial CarcinomaNetherlands
-
Bristol-Myers SquibbCompletedPan TumorUnited States, Puerto Rico, Italy, Argentina, Australia, Belgium, Canada, Chile, Denmark, France, Germany, Netherlands, Poland, Romania, Singapore, Spain, United Kingdom
-
Bristol-Myers SquibbYale UniversityCompletedNon-Small Cell Lung CancerBelgium, Italy, United States, France, Germany, Netherlands, Spain, Romania
-
Bristol-Myers SquibbCompletedVarious Advanced CancerUnited States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, United Kingdom
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedRenal Cell Carcinoma | Metastatic Melanoma | Non-small Cell Lung Cancer | Metastatic Castration-resistant Prostrate CancerUnited States
-
Bristol-Myers SquibbWithdrawnNon-Small Cell Lung CancerArgentina, Peru, Germany, United States, Canada
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of, Finland, Spain, Denmark, Germany, Israel, Japan, Norway, Sweden, Taiwan, United Kingdom
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited Kingdom
-
University of California, San FranciscoNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsRecruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbRecruitingHepatocellular CarcinomaUnited States
-
BeiGeneCompleted
-
National Cancer Institute (NCI)RecruitingBreast Inflammatory CarcinomaUnited States, Canada, Puerto Rico
-
Bristol-Myers SquibbNovartisActive, not recruitingColorectal Cancer | Colorectal Neoplasm | Colorectal Tumors | Colorectal CarcinomaItaly, United States, Canada, Spain, Argentina, Australia, Belgium, Chile, Czechia, Germany
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd; ExelixisActive, not recruitingRenal Cell CarcinomaUnited States, Japan, Brazil, Argentina, Australia, Chile, Czechia, Germany, Greece, Israel, Italy, Mexico, Poland, Romania, Russian Federation, Spain, Turkey, United Kingdom
-
Georgetown UniversityBristol-Myers Squibb; M.D. Anderson Cancer Center; University of Colorado, Denver and other collaboratorsTerminatedMucosal Melanoma | Acral Lentiginous MelanomaUnited States
-
Melanoma Institute AustraliaBristol-Myers Squibb; Melanoma and Skin Cancer Trials LimitedActive, not recruitingMelanoma | Brain MetastasesAustralia
-
University of Michigan Rogel Cancer CenterBristol-Myers SquibbCompletedPeripheral T Cell LymphomaUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbRecruitingLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States, France, Netherlands, Australia, United Kingdom, Italy, Spain, Germany
-
Bristol-Myers SquibbTerminated
-
Royal Marsden NHS Foundation TrustCompletedAdenocarcinoma of OesophagusUnited Kingdom
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedRenal Impairment | Healthy VolunteerUnited States, Czechia, Hungary, Poland
-
Bristol-Myers SquibbCompletedPsoriasisUnited States
-
Bristol-Myers SquibbCompletedRheumatoid ArthritisAustralia
-
Association Pour La Recherche des Thérapeutiques...CompletedClear Cell Metastatic Renal Cell CarcinomaFrance
-
University Hospital, SaarlandBayerCompletedSide-effect of AntibioticGermany
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedHepatitis CUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Northwestern UniversityNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Refractory Adult Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1 | Refractory Childhood Acute Lymphoblastic LeukemiaUnited States